Cytomegolovirus and arterial disease: Present concepts;Cytomegalovirus et pathologies arterielles: Aspects actuels

Archives des Maladies du Coeur et des Vaisseaux

Volumn 92, Issue 9, 1999, Pages 1205-1212

  Lozinguez, O ^b   Arnaud, E ^a   Velut, J G ^b   Tiev, K P ^b   Fiessinger, J N ^b   Emmerich, J ^b  

^a HÔPITAL BROUSSAIS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL PROLIFERATION; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; REVIEW; ANGIOPLASTY; ARTERIOSCLEROSIS; CYTOMEGALIC INCLUSION BODY DISEASE; GRAFT OCCLUSION; HEART TRANSPLANTATION; POSTOPERATIVE COMPLICATION; VIROLOGY;

ANGIOPLASTY; ARTERIOSCLEROSIS; CORONARY DISEASE; CYTOMEGALOVIRUS INFECTIONS; GRAFT OCCLUSION, VASCULAR; HEART TRANSPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS;

EID: 0033193544     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Paterson J, Cottral GE. Experimental coronary atherosclerosis : lymhomatosis as a cause or coronary sclerosis in chickens. Arch Pathol 1950 ; 49 : 699.
2. Fabricant CG, Fabricant J, Litentra MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978 ; 148 : 335-40.
3. Capron L. Infection et athérosclérose. Sang Trhomb Vaiss 1997 ; 9 : 7-9.
4. Mangiavacchi M, Frigerio M, Gronda E et al. Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy. Transplant Proc 1995 ; 27 (3) : 1960-2.
5. Uys CJ, Rose AG. Pathologic findings in long-term cardiac transplants. Arch Pathol Lab Med 1984 ; 108 : 112-6.
6. Kobashigawa JA, Katznelson S, Laks H et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333 (10) : 621-7.
7. Wenke K, Meiser B, Thiery J et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a Four-year randomized trial. Circulation 1997 ; 96 (5) : 1398-402.
8. Demetris AJ, Zerbe T, Banner B. Morphology of solid organ allograft arteriopathy : identification of proliferating intima cell populations. Transplant Proc 1989 ; 21 : 3667-9.
9. Benvenuti C, Nitenberg A, Aptecar E et al. La maladie coronaire du transplanté cardiaque. Arch Mal Cœur 1991 ; 84 (2) : 213-8.
10. Gao SZ, Hunt SA, Schroeder JS et al. Early development of accelerated graft coronary artery disease: risk factors and course. J Am Coll Cardiol 1996 ; 28 (3) : 673-9.
11. Loebe M, Schüler S, Spiegelsberger S et al. Cytomegalovirus infection and coronary sclerosis after heart transplantation. Dtsch Med Wochenschr 1990 ; 115 (34) : 1266-9.
12. Loebe M, Schüler S, Zais O et al. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 1990 ; 9 (6) : 707-11.
13. McGiffin DC, Savunen T, Kirklin JK et al. Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events. J Thorac Cardiovasc Surg 1995 ; 109 (6) : 1081-8.
14. McDonald K, Rector TS, Braulin EA et al. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989 ; 64 (5) : 359-62.
15. Everett JP, Hershberger RE, Norman DJ et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992 ; 11(3 Pt 2): S 133-S 137.
16. Grattan MT, Moreno-Cabral CE, Starnes VA et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989 ; 261 (24) : 3561-6.
17. Wu TC, Hruban RH, Ambinder RF et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 1992 ; 140 (3) : 739-47.
18. Gulizia JM, Kandolf R, Kendall TJ et al. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 1995 ; 147 (2): 461-75.
19. Skowronski EW, Mendoza A, Smith SC Jr, Jaski BE. Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction: of cytomegalovirus association with graft atherosclerosis. J Heart Lung Transplant 1993 ; 12 (5) : 717-23.
20. Koskinen PK, Nieminen MS, Krogerus LA et al. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993 ; 12 (5): 724-9.
21. Leimgruber PP, Roubin GS, Hollman J et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986 ; 73 (4) : 710-7.
22. Ellis SG, Roubin GS, King SB 3d et al. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty. Am J Cardiol 1989 ; 63 (1) : 30-4.
23. Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994 ; 331 (8) : 496-501.
24. Serruys PW, de Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994 ; 331 (8) : 489-95.
25. Speir E, Modali R, Huang ES et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1991 ; 265 : 391-4.
26. Zhou YF, Leon Mb, Waclawiw MA et al. Association between prior cytomegalovirus infection and the risk of restenosis after cornary atherectomy. N Engl J Med 1996 ; 335 : 624-30.
27. Blum A, Gilaldi M, Weinberg M et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 1998 ; 81 (7) : 866-8.
28. Thomas W, Lele S, Adler S, Goudreau E, Cowley M, Vetrovec GW. Lack of evidence for relationship between cytomegalovirus status in coronary angiographic restenosis (abstract). Circulation 1997 ; 96 : 1-650
29. Muhlestein JB, Carlquist JF, Horne BD et al. No association between proir cyromegalovirus infection and the risk of cliniacl restenosis after percutaneous coronary interventions (abstract). Circulation. 1997 ;96 : 1-650.
30. Carlsson J, Karl-Heinz M, Miketic S et al. Prior Cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary angioplasty: results from the VERAS study (abstract). Circulation 1997 ; 96 : 1-650.
31. Manegold C, Alwazzeh M, Jablonowski H et al. Prior Cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Circulation 1999 ; 99 : 1290-4.
32. Pauletto P, Pisoni G, Boschetto R et al. Cytomegalovirus and restenosis of the internal carotid artery. Stroke 1996 ; 27 (9) : 1669-71.
33. Steinberg D, Parthasarathy S, Carew TE et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989 ; 320 (14) : 915-24.
34. Anderson JL, Carlquist JF, Muhlestein JB et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998 ; 32 (1) : 35-41.
35. Adam E, Meluick JL, Probtsfield JL et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987 ; 2 (8554) : 291-3.
36. Nieto FJ, Adam E, Sorlie P et al. Cohort study of cytomegalovirus infection as a risk Factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1976 ; 94 (5) : 922-7.
37. Cour MI, Lopez de Atalaya FJ, Palau L et al. Lack of serological association between herpesvirus and atherosclerosis. Lancet 1989 ; 1 (8632) : 279.
38. Dummer S, Lee A, Breinig MK et al. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 1994 ; 44 (3) : 305-9
39. Sorlie PD, Adam E, Melnick JL et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol 1994 ; 42 (1) : 33-7.
40. Adler SP, Hur JK, Wang JB, Vertrovec GW. Prior infection with cytomegalovirus is not a major risk Factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis 1998 ; 177 (1) : 209-12.
41. Ossewaarde JM, Feskens EJ, De Vries A et al. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998 ; 120 (1) : 93-9.
42. Artieda P, Cour MI, Ortega P et al. Cytomegalovirus: prevalence of antibodies in a control group. Rev Clin Esp 1986 ; 179 (1) : 8-11.
43. Cour MI, Lopez Bartolomé O, Ortega P et al. Citomegalovirus : un estudio en 4 977 mujeres gestantes. Med Clin 1988 ; 90 : 225-8.
44. Cour MI, Diéguez RA, Minguez F. Herpes simplex : estudio seroepidemilogico en Madrid (S. Sebastian de los Reyes y Arnjeuz) y Toledo (Talavera de la reina). Enf Infect Microbiol Clin 1988 ; 6 : 190-4.
45. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997 ; 350 (9075) : 430-6.
46. Melnick JL, Adam E, De Bakey ME. Cytomegalovirus and atherosclerosis. Eur Heart J 1993 ; 14 (suppl K) : 30-8.
47. Melnick JL, Hu C, Burek J et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994 ; 42 (2) : 170-4.
48. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997 ; 96 (7) : 2144-8.
49. Hendrix MG, Salimans MM, Van Boven PP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990 ; 136 (1) : 23-8.
50. Hendrix MG, Daeman M, Briggeman CA. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991 ; 138 (3) : 563-7.
51. Yamashiroya HM, Ghosh L, Yang R, Robertson AL Jr. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988 ; 130 (1) : 71-9.
52. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983 ; 80 (20) : 6386-9.
53. Tumilowicz JJ, Gawlik ME, Powell BB, Trentin JJ. Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol 1985 ; 56 (3) : 839-45.
54. Kol A, Sperti G, Shani J et al. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 1995 ; 91 (7) : 1910-3.
55. Sutherland MR, Raynor CM, Leeknegt H et al. Coagulation initiated on herpesviruses. Proc Natl Acad Sci USA 1997 ; 94 (25) : 13510-4.
56. Pryzdial EL, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid. Blood 1994 ; 84 (11) : 3749-57.
57. Vercellotti GM. Effects of viral activation of the vessel wall on inflammation and thrombosis. Blood Coag Fibrin 1998 ; (suppl 2) : S 3-S 6.
58. Nieto FJ, Sorlie P, Comstock GW et al. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atheroqenic link? Arterioscler Thromb Vasc Biol 1997 ; 17 (9) : 1780-5.
59. Span AH, Van Dam-Mieras MC, Mullers W et al. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest 1991 ; 21 (3) : 331-8.
60. Tanaka S, Komori K, Okadome K et al. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg 1994 ; 20 (2) : 235-43.